Millenium and Cohausz & Florack successfully defend Velcade patent in Germany
Millenium Pharmaceuticals is defending the patents EP 2 251 344 B1 and EP 3 078 667 B1 in Germany and other countries. Both protect a formulation of boronic acid compounds. They form the basis of anti-cancer medication Velcade with the active ingredient bortezomib.